86Q Stock Overview
A biotechnology company, develops and produces forest-based capsaicin and analogues.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
XP Chemistries AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.011 |
| 52 Week High | SEK 0.045 |
| 52 Week Low | SEK 0.002 |
| Beta | 1.45 |
| 11 Month Change | 43.75% |
| 3 Month Change | 360.00% |
| 1 Year Change | -72.62% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 86Q | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -4.2% | 0.06% | 0.8% |
| 1Y | -72.6% | 8.1% | 6.1% |
Return vs Industry: 86Q underperformed the German Chemicals industry which returned 8.1% over the past year.
Return vs Market: 86Q underperformed the German Market which returned 6.1% over the past year.
Price Volatility
| 86Q volatility | |
|---|---|
| 86Q Average Weekly Movement | 37.2% |
| Chemicals Industry Average Movement | 4.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 86Q's share price has been volatile over the past 3 months.
Volatility Over Time: 86Q's weekly volatility has increased from 25% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 3 | Erik Nelsson | www.xpchemistries.com |
XP Chemistries AB (publ), a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. XP Chemistries AB (publ) was incorporated in 2018 and is based in Sundsvall, Sweden.
XP Chemistries AB (publ) Fundamentals Summary
| 86Q fundamental statistics | |
|---|---|
| Market cap | €1.35m |
| Earnings (TTM) | -€689.83k |
| Revenue (TTM) | €38.99k |
34.6x
P/S Ratio-2.0x
P/E RatioIs 86Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 86Q income statement (TTM) | |
|---|---|
| Revenue | SEK 443.12k |
| Cost of Revenue | SEK 195.47k |
| Gross Profit | SEK 247.65k |
| Other Expenses | SEK 8.09m |
| Earnings | -SEK 7.84m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 55.89% |
| Net Profit Margin | -1,769.33% |
| Debt/Equity Ratio | 0% |
How did 86Q perform over the long term?
See historical performance and comparison